APA (7th ed.) Citation

National Research Tomsk Polytechnic University, Chernov V. I. Vladimir Ivanovich, Rybina A. N. Anastasiya Nikolaevna, Zelchan R. V. Roman Vladimirovich, Medvedeva А. А. Anna Aleksandrovna, Bragina O. D. Olga Dmitrievna, . . . Orlova A. M. Anna Markovna. (2023). Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. 2023. https://doi.org/10.3390/cancers15061631

Chicago Style (17th ed.) Citation

National Research Tomsk Polytechnic University, et al. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. 2023, 2023. https://doi.org/10.3390/cancers15061631.

MLA (9th ed.) Citation

National Research Tomsk Polytechnic University, et al. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. 2023, 2023. https://doi.org/10.3390/cancers15061631.

Warning: These citations may not always be 100% accurate.